COVID-19 Healthcare Coalition Response Series Webinar
Researchers and clinicians are working hard to develop immune therapies to treat COVID-19—including the use of convalescent plasma and hyperimmune globulin. In this exclusive webinar, health experts examine how these antibody-rich blood products from recovered COVID-19 patients are already impacting care and informing research in monoclonal antibodies and vaccines.
Questions to consider:
What does the latest research tell us about the effectiveness of convalescent plasma and immune therapies? What does the future hold for these therapies?
Webinar Panelists:
Mark McClellan, MD, PhD, Director, Duke-Margolis Center for Health Policy
Nigel Paneth, MD, MPH, University Distinguished Professor of Epidemiology & Biostatistics & Pediatrics, Michigan State University
Nicholas King, kidney transplant recipient, recent COVID-19 patient
William Mezzanotte, MD, MPH, Executive Vice President and Head of R&D, CSL Behring
Important Resources:
For the latest insights and updates from the COVID-19 Healthcare Coalition, visit
The COVID-19 Decision Support Dashboard gives you the information you need in one place to make critical decisions.
